Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma

Lung adenocarcinoma (LUAD), the most common histological type of non-small cell lung cancer, is one of the most malignant and deadly diseases. Current treatments for advanced LUAD patients are far from ideal and require further improvements. Here, we utilized a systematic integrative analysis of LUA...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shu-Hsuan, Hsu, Kai-Wen, Lai, Yo-Liang, Lin, Yu-Feng, Chen, Fang-Hsin, Peng, Pei-Hwa, Lin, Li-Jie, Wu, Heng-Hsiung, Li, Chia-Yang, Wang, Shu-Chi, Wu, Min-Zu, Sher, Yuh-Pyng, Cheng, Wei-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181588/
https://www.ncbi.nlm.nih.gov/pubmed/34141460
http://dx.doi.org/10.1016/j.omtn.2021.04.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181588/
https://www.ncbi.nlm.nih.gov/pubmed/34141460
http://dx.doi.org/10.1016/j.omtn.2021.04.020

Ejemplares similares